ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 177 filers reported holding ARGENX SE in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,413,528 | +168.8% | 4,910 | +113.0% | 0.00% | +100.0% |
| Q2 2023 | $897,843 | +10.7% | 2,305 | +5.9% | 0.00% | 0.0% |
| Q1 2023 | $810,833 | -0.6% | 2,176 | +1.1% | 0.00% | 0.0% |
| Q4 2022 | $815,652 | +6.2% | 2,153 | -1.0% | 0.00% | 0.0% |
| Q3 2022 | $768,000 | -55.0% | 2,174 | -51.9% | 0.00% | -50.0% |
| Q2 2022 | $1,706,000 | +244.6% | 4,517 | +187.7% | 0.00% | +300.0% |
| Q1 2022 | $495,000 | +8.1% | 1,570 | +20.3% | 0.00% | 0.0% |
| Q4 2021 | $458,000 | +29.7% | 1,305 | +11.1% | 0.00% | 0.0% |
| Q3 2021 | $353,000 | +11.4% | 1,175 | +11.4% | 0.00% | 0.0% |
| Q2 2021 | $317,000 | -35.2% | 1,055 | -40.5% | 0.00% | 0.0% |
| Q1 2021 | $489,000 | +5.8% | 1,774 | +13.1% | 0.00% | 0.0% |
| Q4 2020 | $462,000 | +10.0% | 1,568 | -1.8% | 0.00% | 0.0% |
| Q3 2020 | $420,000 | +23.9% | 1,597 | +5.8% | 0.00% | 0.0% |
| Q2 2020 | $339,000 | +98.2% | 1,509 | +16.0% | 0.00% | 0.0% |
| Q1 2020 | $171,000 | – | 1,301 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 49,950 | $14,690,000 | 5.25% |
| Avoro Capital Advisors LLC | 902,500 | $265,416,000 | 4.57% |
| Eagle Health Investments LP | 19,587 | $5,760,000 | 3.68% |
| Redmile Group, LLC | 918,307 | $270,065,000 | 3.27% |
| Bellevue Group AG | 945,348 | $278,018,000 | 3.18% |
| AWM Investment Company, Inc. | 80,000 | $23,527,000 | 2.99% |
| DCF Advisers, LLC | 24,000 | $7,058,000 | 2.91% |
| Ikarian Capital, LLC | 201,500 | $59,260,000 | 2.61% |
| JGP Global Gestao de Recursos Ltda. | 1,859 | $547,000 | 2.06% |
| Evolutionary Tree Capital Management, LLC | 8,798 | $2,587,000 | 1.97% |